Biospecimen reporting for improved study quality (BRISQ)
Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent a...
Gespeichert in:
| Veröffentlicht in: | Cancer cytopathology 2011-04, Vol.119 (2), p.92-102 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 102 |
|---|---|
| container_issue | 2 |
| container_start_page | 92 |
| container_title | Cancer cytopathology |
| container_volume | 119 |
| creator | Moore, Helen M. Kelly, Andrea B. Jewell, Scott D. McShane, Lisa M. Clark, Douglas P. Greenspan, Renata Hayes, Daniel F. Hainaut, Pierre Kim, Paula Mansfield, Elizabeth A. Potapova, Olga Riegman, Peter Rubinstein, Yaffa Seijo, Edward Somiari, Stella Watson, Peter Weier, Heinz‐Ulrich Zhu, Claire Vaught, Jim |
| description | Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research that uses human tissues, it is crucial that information on the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications on biospecimen‐related research and to help reassure patient contributors and the advocacy community that their contributions are valued and respected. Cancer (Cancer Cytopathol) 2011. Published 2011 by the American Cancer Society.
Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. The BRISQ guidelines are proposed as an important and timely tool to strengthen communication and publications on biospecimen‐related research. |
| doi_str_mv | 10.1002/cncy.20147 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_862268553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>862268553</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4607-9d2a0daea624ad5b97a8aec9f2ded2490fff63dc10df7c0b6713206e108dab613</originalsourceid><addsrcrecordid>eNp90EtLw0AQB_BFFFurFz-A5CI-IHUf6SY52uCjUBRfoKdlsw9Zyau7iZJvb2pivXmaGfgxM_wBOERwiiDEF6IQ7RRDFIRbYIxiEviUkmh70-PXEdhz7gNCFIUY7YIRRgEh3TgG0dyUrlLC5KrwrKpKW5vi3dOl9Uxe2fJTSc_VjWy9VcMzU7fe6fxx8fRwtg92NM-cOhjqBLxcXz0nt_7y_maRXC59EVAY-rHEHEquOMUBl7M0DnnElYg1lkriIIZaa0qkQFDqUMCUhohgSBWCkeQpRWQCTvq93TOrRrma5cYJlWW8UGXjWEQxptFsRjp53kthS-es0qyyJue2ZQiydVBsHRT7CarDR8PaJs2V3NDfZDpwPADuBM-05YUw7s8F3Z8hjjuHevdlMtX-c5Ild8lbf_wbwQx_tA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>862268553</pqid></control><display><type>article</type><title>Biospecimen reporting for improved study quality (BRISQ)</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Moore, Helen M. ; Kelly, Andrea B. ; Jewell, Scott D. ; McShane, Lisa M. ; Clark, Douglas P. ; Greenspan, Renata ; Hayes, Daniel F. ; Hainaut, Pierre ; Kim, Paula ; Mansfield, Elizabeth A. ; Potapova, Olga ; Riegman, Peter ; Rubinstein, Yaffa ; Seijo, Edward ; Somiari, Stella ; Watson, Peter ; Weier, Heinz‐Ulrich ; Zhu, Claire ; Vaught, Jim</creator><creatorcontrib>Moore, Helen M. ; Kelly, Andrea B. ; Jewell, Scott D. ; McShane, Lisa M. ; Clark, Douglas P. ; Greenspan, Renata ; Hayes, Daniel F. ; Hainaut, Pierre ; Kim, Paula ; Mansfield, Elizabeth A. ; Potapova, Olga ; Riegman, Peter ; Rubinstein, Yaffa ; Seijo, Edward ; Somiari, Stella ; Watson, Peter ; Weier, Heinz‐Ulrich ; Zhu, Claire ; Vaught, Jim</creatorcontrib><description>Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research that uses human tissues, it is crucial that information on the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications on biospecimen‐related research and to help reassure patient contributors and the advocacy community that their contributions are valued and respected. Cancer (Cancer Cytopathol) 2011. Published 2011 by the American Cancer Society.
Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. The BRISQ guidelines are proposed as an important and timely tool to strengthen communication and publications on biospecimen‐related research.</description><identifier>ISSN: 1934-662X</identifier><identifier>EISSN: 1934-6638</identifier><identifier>DOI: 10.1002/cncy.20147</identifier><identifier>PMID: 21433001</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>best practices ; biobank ; Biological and medical sciences ; Biological Specimen Banks - standards ; Biomedical Research - standards ; biospecimen ; BRISQ ; General aspects ; guidelines ; human ; Humans ; Medical sciences ; quality ; Quality Control ; Reference Standards ; Specimen Handling - standards ; Tumors</subject><ispartof>Cancer cytopathology, 2011-04, Vol.119 (2), p.92-102</ispartof><rights>Copyright © 2011 American Cancer Society</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 American Cancer Society.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4607-9d2a0daea624ad5b97a8aec9f2ded2490fff63dc10df7c0b6713206e108dab613</citedby><cites>FETCH-LOGICAL-c4607-9d2a0daea624ad5b97a8aec9f2ded2490fff63dc10df7c0b6713206e108dab613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncy.20147$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncy.20147$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27928,27929,45578,45579,46413,46837</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24132729$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21433001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, Helen M.</creatorcontrib><creatorcontrib>Kelly, Andrea B.</creatorcontrib><creatorcontrib>Jewell, Scott D.</creatorcontrib><creatorcontrib>McShane, Lisa M.</creatorcontrib><creatorcontrib>Clark, Douglas P.</creatorcontrib><creatorcontrib>Greenspan, Renata</creatorcontrib><creatorcontrib>Hayes, Daniel F.</creatorcontrib><creatorcontrib>Hainaut, Pierre</creatorcontrib><creatorcontrib>Kim, Paula</creatorcontrib><creatorcontrib>Mansfield, Elizabeth A.</creatorcontrib><creatorcontrib>Potapova, Olga</creatorcontrib><creatorcontrib>Riegman, Peter</creatorcontrib><creatorcontrib>Rubinstein, Yaffa</creatorcontrib><creatorcontrib>Seijo, Edward</creatorcontrib><creatorcontrib>Somiari, Stella</creatorcontrib><creatorcontrib>Watson, Peter</creatorcontrib><creatorcontrib>Weier, Heinz‐Ulrich</creatorcontrib><creatorcontrib>Zhu, Claire</creatorcontrib><creatorcontrib>Vaught, Jim</creatorcontrib><title>Biospecimen reporting for improved study quality (BRISQ)</title><title>Cancer cytopathology</title><addtitle>Cancer Cytopathol</addtitle><description>Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research that uses human tissues, it is crucial that information on the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications on biospecimen‐related research and to help reassure patient contributors and the advocacy community that their contributions are valued and respected. Cancer (Cancer Cytopathol) 2011. Published 2011 by the American Cancer Society.
Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. The BRISQ guidelines are proposed as an important and timely tool to strengthen communication and publications on biospecimen‐related research.</description><subject>best practices</subject><subject>biobank</subject><subject>Biological and medical sciences</subject><subject>Biological Specimen Banks - standards</subject><subject>Biomedical Research - standards</subject><subject>biospecimen</subject><subject>BRISQ</subject><subject>General aspects</subject><subject>guidelines</subject><subject>human</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>quality</subject><subject>Quality Control</subject><subject>Reference Standards</subject><subject>Specimen Handling - standards</subject><subject>Tumors</subject><issn>1934-662X</issn><issn>1934-6638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90EtLw0AQB_BFFFurFz-A5CI-IHUf6SY52uCjUBRfoKdlsw9Zyau7iZJvb2pivXmaGfgxM_wBOERwiiDEF6IQ7RRDFIRbYIxiEviUkmh70-PXEdhz7gNCFIUY7YIRRgEh3TgG0dyUrlLC5KrwrKpKW5vi3dOl9Uxe2fJTSc_VjWy9VcMzU7fe6fxx8fRwtg92NM-cOhjqBLxcXz0nt_7y_maRXC59EVAY-rHEHEquOMUBl7M0DnnElYg1lkriIIZaa0qkQFDqUMCUhohgSBWCkeQpRWQCTvq93TOrRrma5cYJlWW8UGXjWEQxptFsRjp53kthS-es0qyyJue2ZQiydVBsHRT7CarDR8PaJs2V3NDfZDpwPADuBM-05YUw7s8F3Z8hjjuHevdlMtX-c5Ild8lbf_wbwQx_tA</recordid><startdate>20110425</startdate><enddate>20110425</enddate><creator>Moore, Helen M.</creator><creator>Kelly, Andrea B.</creator><creator>Jewell, Scott D.</creator><creator>McShane, Lisa M.</creator><creator>Clark, Douglas P.</creator><creator>Greenspan, Renata</creator><creator>Hayes, Daniel F.</creator><creator>Hainaut, Pierre</creator><creator>Kim, Paula</creator><creator>Mansfield, Elizabeth A.</creator><creator>Potapova, Olga</creator><creator>Riegman, Peter</creator><creator>Rubinstein, Yaffa</creator><creator>Seijo, Edward</creator><creator>Somiari, Stella</creator><creator>Watson, Peter</creator><creator>Weier, Heinz‐Ulrich</creator><creator>Zhu, Claire</creator><creator>Vaught, Jim</creator><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110425</creationdate><title>Biospecimen reporting for improved study quality (BRISQ)</title><author>Moore, Helen M. ; Kelly, Andrea B. ; Jewell, Scott D. ; McShane, Lisa M. ; Clark, Douglas P. ; Greenspan, Renata ; Hayes, Daniel F. ; Hainaut, Pierre ; Kim, Paula ; Mansfield, Elizabeth A. ; Potapova, Olga ; Riegman, Peter ; Rubinstein, Yaffa ; Seijo, Edward ; Somiari, Stella ; Watson, Peter ; Weier, Heinz‐Ulrich ; Zhu, Claire ; Vaught, Jim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4607-9d2a0daea624ad5b97a8aec9f2ded2490fff63dc10df7c0b6713206e108dab613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>best practices</topic><topic>biobank</topic><topic>Biological and medical sciences</topic><topic>Biological Specimen Banks - standards</topic><topic>Biomedical Research - standards</topic><topic>biospecimen</topic><topic>BRISQ</topic><topic>General aspects</topic><topic>guidelines</topic><topic>human</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>quality</topic><topic>Quality Control</topic><topic>Reference Standards</topic><topic>Specimen Handling - standards</topic><topic>Tumors</topic><toplevel>online_resources</toplevel><creatorcontrib>Moore, Helen M.</creatorcontrib><creatorcontrib>Kelly, Andrea B.</creatorcontrib><creatorcontrib>Jewell, Scott D.</creatorcontrib><creatorcontrib>McShane, Lisa M.</creatorcontrib><creatorcontrib>Clark, Douglas P.</creatorcontrib><creatorcontrib>Greenspan, Renata</creatorcontrib><creatorcontrib>Hayes, Daniel F.</creatorcontrib><creatorcontrib>Hainaut, Pierre</creatorcontrib><creatorcontrib>Kim, Paula</creatorcontrib><creatorcontrib>Mansfield, Elizabeth A.</creatorcontrib><creatorcontrib>Potapova, Olga</creatorcontrib><creatorcontrib>Riegman, Peter</creatorcontrib><creatorcontrib>Rubinstein, Yaffa</creatorcontrib><creatorcontrib>Seijo, Edward</creatorcontrib><creatorcontrib>Somiari, Stella</creatorcontrib><creatorcontrib>Watson, Peter</creatorcontrib><creatorcontrib>Weier, Heinz‐Ulrich</creatorcontrib><creatorcontrib>Zhu, Claire</creatorcontrib><creatorcontrib>Vaught, Jim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer cytopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Helen M.</au><au>Kelly, Andrea B.</au><au>Jewell, Scott D.</au><au>McShane, Lisa M.</au><au>Clark, Douglas P.</au><au>Greenspan, Renata</au><au>Hayes, Daniel F.</au><au>Hainaut, Pierre</au><au>Kim, Paula</au><au>Mansfield, Elizabeth A.</au><au>Potapova, Olga</au><au>Riegman, Peter</au><au>Rubinstein, Yaffa</au><au>Seijo, Edward</au><au>Somiari, Stella</au><au>Watson, Peter</au><au>Weier, Heinz‐Ulrich</au><au>Zhu, Claire</au><au>Vaught, Jim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biospecimen reporting for improved study quality (BRISQ)</atitle><jtitle>Cancer cytopathology</jtitle><addtitle>Cancer Cytopathol</addtitle><date>2011-04-25</date><risdate>2011</risdate><volume>119</volume><issue>2</issue><spage>92</spage><epage>102</epage><pages>92-102</pages><issn>1934-662X</issn><eissn>1934-6638</eissn><abstract>Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research that uses human tissues, it is crucial that information on the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications on biospecimen‐related research and to help reassure patient contributors and the advocacy community that their contributions are valued and respected. Cancer (Cancer Cytopathol) 2011. Published 2011 by the American Cancer Society.
Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. The BRISQ guidelines are proposed as an important and timely tool to strengthen communication and publications on biospecimen‐related research.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>21433001</pmid><doi>10.1002/cncy.20147</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1934-662X |
| ispartof | Cancer cytopathology, 2011-04, Vol.119 (2), p.92-102 |
| issn | 1934-662X 1934-6638 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_862268553 |
| source | MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals |
| subjects | best practices biobank Biological and medical sciences Biological Specimen Banks - standards Biomedical Research - standards biospecimen BRISQ General aspects guidelines human Humans Medical sciences quality Quality Control Reference Standards Specimen Handling - standards Tumors |
| title | Biospecimen reporting for improved study quality (BRISQ) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T08%3A49%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biospecimen%20reporting%20for%20improved%20study%20quality%20(BRISQ)&rft.jtitle=Cancer%20cytopathology&rft.au=Moore,%20Helen%20M.&rft.date=2011-04-25&rft.volume=119&rft.issue=2&rft.spage=92&rft.epage=102&rft.pages=92-102&rft.issn=1934-662X&rft.eissn=1934-6638&rft_id=info:doi/10.1002/cncy.20147&rft_dat=%3Cproquest_cross%3E862268553%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=862268553&rft_id=info:pmid/21433001&rfr_iscdi=true |